STOCK TITAN

Chime director Feuille sells 351K shares at ~$33

Chime Financial director James Feuille reported fund-related sales totaling 351,890 Class A shares around $33, while retaining substantial indirect and direct holdings.

(Very High)
(Very Negative)
Form Type
4

Rhea-AI Filing Summary

Chime Financial, Inc. (CHYM) director James Feuille reported indirect sales of an aggregate 351,890 shares of Class A Common Stock on September 10–11, 2026 through investment entities he helps manage. Reported weighted-average sale prices were around $32.89–$33.15 per share, with actual trade prices occurring within stated ranges.

The filing shows 34,411 shares held by Crosslink Ventures VII Holdings, LLC after its sale, plus continuing indirect holdings of 8,926,768 shares by Crosslink Ventures VII, L.P., 3,825,152 shares by Crosslink Ventures VII-B, L.P., 945,704 shares by Crosslink Bayview VII, LLC, and 23,315 shares held directly. Feuille disclaims beneficial ownership of many of these positions except for his pecuniary interest, and no Rule 10b5-1 trading plan is reported.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider Feuille James
Role Director
Sold 351,890 shs ($11.61M)
Type Security Shares Price Value
Sale Class A Common Stock F3, F2 97,308 $33.0286 $3.21M
Sale Class A Common Stock F4, F5, F6 161,090 $32.8897 $5.30M
Sale Class A Common Stock F1, F2 93,492 $33.1476 $3.10M
holding Class A Common Stock F7, F8 -- -- --
holding Class A Common Stock F9, F10 -- -- --
holding Class A Common Stock F11, F12 -- -- --
holding Class A Common Stock F13 -- -- --
holding Class A Common Stock F14 -- -- --
holding Class A Common Stock -- -- --
Holdings After Transaction: Class A Common Stock — 6,846,907 shares (Indirect, By Crosslink Crossover Fund VI, L.P.); Class A Common Stock — 34,411 shares (Indirect, By Crosslink Ventures VII Holdings, LLC); Class A Common Stock — 8,926,768 shares (Indirect, By Crosslink Ventures VII, L.P.); Class A Common Stock — 3,825,152 shares (Indirect, Crosslink Ventures VII-B, L.P.); Class A Common Stock — 945,704 shares (Indirect, By Crosslink Bayview VII, LLC); Class A Common Stock — 138,972 shares (Indirect, By Trust); Class A Common Stock — 23,315 shares (Direct)
Footnotes (14)
  1. F1. The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $33.01 to $33.44, inclusive. The Reporting Person undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
  2. F2. Shares are directly held by Crosslink Crossover Fund VI, L.P. ("CO VI"). Crossover Fund VI Management, L.L.C. ("CF VI Mgr") is the general partner of CO VI and the Reporting Person is a managing member of CF VI Mgr. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
  3. F3. The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $32.95 to $33.18, inclusive. The Reporting Person undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
  4. F4. The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $32.40 to $33.08, inclusive. The Reporting Person undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
  5. F5. The shares held by Crosslink Ventures VII Holdings, LLC ("CV VII Hldgs") as reported herein reflect the receipt of shares pursuant to pro rata distributions in kind, effected by CB VII and CB VII-B, for no additional consideration subsequent to the Reporting Person's most recent Form 4 filing, which were exempt from reporting pursuant to Rule 16a-13.
  6. F6. Shares are directly held by CV VII Hldgs. The Reporting Person is a managing member of CV VII Hldgs and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
  7. F7. 3. The shares held by Crosslink Ventures VII, L.P. ("CV VII") as reported herein reflect pro rata distributions in kind, effected by CV VII to its general partner and limited partners for no additional consideration subsequent to the Reporting Person's most recent Form 4 filing, which were exempt from reporting pursuant to Rule 16a-13.
  8. F8. Shares are directly held by CV VII. Crosslink Ventures VII Holdings, LLC ("CV VII Hldgs") is the general partner of CV VII and the Reporting Person is a managing member of CV VII Hldgs. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
  9. F9. The shares held by Crosslink Ventures VII-B, L.P. ("CV VII-B") as reported herein reflect pro rata distributions in kind, effected by CV VII-B to its general partner and limited partners for no additional consideration subsequent to the Reporting Person's most recent Form 4 filing, which were exempt from reporting pursuant to Rule 16a-13.
  10. F10. Shares are directly held by CV VII-B. CV VII Hldgs is the general partner of CV VII-B and the Reporting Person is a managing member of CV VII Hldgs. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
  11. F11. The shares held by Crosslink Bayview VII, LLC ("CB VII") as reported herein reflect pro rata distributions in kind, effected by CB VII to its members for no additional consideration subsequent to the Reporting Person's most recent Form 4 filing, which were exempt from reporting pursuant to Rule 16a-13.
  12. F12. Shares are directly held by CB VII. CV VII Hldgs is the manager of CB VII and the Reporting Person is a managing member of CV VII Hldgs. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
  13. F13. The shares are held by an irrevocable trust, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his proportionate pecuniary interest therein.
  14. F14. The shares are held by a revocable trust, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his proportionate pecuniary interest therein.
Total shares sold 351,890 shares Aggregate Class A Common Stock sales reported for September 10–11, 2026
Shares sold September 10, 2026 93,492 shares Class A Common Stock sold at a weighted-average price of $33.1476 per share
Shares sold September 11, 2026 (Crosslink Crossover Fund VI, L.P.) 97,308 shares Class A Common Stock sold at a weighted-average price of $33.0286 per share
Shares sold September 11, 2026 (Crosslink Ventures VII Holdings, LLC) 161,090 shares Class A Common Stock sold at a weighted-average price of $32.8897 per share
Post-transaction holdings of Crosslink Ventures VII Holdings, LLC 34,411 shares Class A Common Stock held after September 11, 2026 sale
Holdings of Crosslink Ventures VII, L.P. 8,926,768 shares Indirect Class A Common Stock position reported as of September 10, 2026
Holdings of Crosslink Ventures VII-B, L.P. 3,825,152 shares Indirect Class A Common Stock position reported as of September 10, 2026
Direct holdings of James Feuille 23,315 shares Class A Common Stock held directly as of September 10, 2026
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
pro rata distributions in kind financial
"reflect pro rata distributions in kind, effected by CV VII to its general partner"
Rule 16a-13 regulatory
"which were exempt from reporting pursuant to Rule 16a-13."
pecuniary interest financial
"disclaims beneficial ownership of these shares except to the extent of his pecuniary interest"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Chime Financial (CHYM) director James Feuille report in this Form 4?

He reported indirect sales of 351,890 shares of Chime Financial Class A Common Stock on September 10–11, 2026 through affiliated investment entities, at weighted-average prices near $33 per share, while retaining substantial indirect and direct holdings as detailed in the filing.

How many CHYM shares were sold on September 10, 2026?

On September 10, 2026, entities associated with James Feuille sold 93,492 shares of Chime Financial Class A Common Stock at a weighted-average price of $33.1476 per share, with actual transaction prices ranging from $33.01 to $33.44 according to the footnote.

What CHYM share sales occurred on September 11, 2026?

On September 11, 2026, entities associated with James Feuille sold 97,308 shares at a weighted-average price of $33.0286 and 161,090 shares at $32.8897, with actual prices within stated ranges from $32.40 to $33.18, all in Class A Common Stock.

What other indirect CHYM holdings are reported for entities linked to James Feuille?

Indirectly, the filing reports 8,926,768 shares held by Crosslink Ventures VII, L.P., 3,825,152 shares by Crosslink Ventures VII-B, L.P., and 945,704 shares by Crosslink Bayview VII, LLC, with Feuille disclaiming beneficial ownership beyond his pecuniary interest in these entities.

Does James Feuille hold any CHYM shares directly?

Yes. The Form 4 reports a direct holding of 23,315 shares of Chime Financial Class A Common Stock by James Feuille as of September 10, 2026, in addition to his various indirect holdings through funds and trusts.

Were the CHYM share sales under a Rule 10b5-1 trading plan?

No. The Form 4 indicates that no Rule 10b5-1 trading plan was affirmed for these transactions, and the footnotes do not state that the reported sales were executed under any such pre-arranged trading arrangement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Feuille James

(Last)(First)(Middle)
C/O CHIME FINANCIAL, INC.
101 CALIFORNIA STREET, SUITE 500

(Street)
SAN FRANCISCO CALIFORNIA 94111

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Chime Financial, Inc. [ CHYM ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/10/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock09/10/2026S93,492D$33.1476(1)6,944,215IBy Crosslink Crossover Fund VI, L.P.(2)
Class A Common Stock09/11/2026S97,308D$33.0286(3)6,846,907IBy Crosslink Crossover Fund VI, L.P.(2)
Class A Common Stock09/11/2026S161,090D$32.8897(4)34,411(5)IBy Crosslink Ventures VII Holdings, LLC(6)
Class A Common Stock8,926,768(7)IBy Crosslink Ventures VII, L.P.(8)
Class A Common Stock3,825,152(9)ICrosslink Ventures VII-B, L.P.(10)
Class A Common Stock945,704(11)IBy Crosslink Bayview VII, LLC(12)
Class A Common Stock93,726IBy Trust(13)
Class A Common Stock45,246IBy Trust(14)
Class A Common Stock23,315D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $33.01 to $33.44, inclusive. The Reporting Person undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
2. Shares are directly held by Crosslink Crossover Fund VI, L.P. ("CO VI"). Crossover Fund VI Management, L.L.C. ("CF VI Mgr") is the general partner of CO VI and the Reporting Person is a managing member of CF VI Mgr. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
3. The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $32.95 to $33.18, inclusive. The Reporting Person undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
4. The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $32.40 to $33.08, inclusive. The Reporting Person undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
5. The shares held by Crosslink Ventures VII Holdings, LLC ("CV VII Hldgs") as reported herein reflect the receipt of shares pursuant to pro rata distributions in kind, effected by CB VII and CB VII-B, for no additional consideration subsequent to the Reporting Person's most recent Form 4 filing, which were exempt from reporting pursuant to Rule 16a-13.
6. Shares are directly held by CV VII Hldgs. The Reporting Person is a managing member of CV VII Hldgs and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
7. 3. The shares held by Crosslink Ventures VII, L.P. ("CV VII") as reported herein reflect pro rata distributions in kind, effected by CV VII to its general partner and limited partners for no additional consideration subsequent to the Reporting Person's most recent Form 4 filing, which were exempt from reporting pursuant to Rule 16a-13.
8. Shares are directly held by CV VII. Crosslink Ventures VII Holdings, LLC ("CV VII Hldgs") is the general partner of CV VII and the Reporting Person is a managing member of CV VII Hldgs. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
9. The shares held by Crosslink Ventures VII-B, L.P. ("CV VII-B") as reported herein reflect pro rata distributions in kind, effected by CV VII-B to its general partner and limited partners for no additional consideration subsequent to the Reporting Person's most recent Form 4 filing, which were exempt from reporting pursuant to Rule 16a-13.
10. Shares are directly held by CV VII-B. CV VII Hldgs is the general partner of CV VII-B and the Reporting Person is a managing member of CV VII Hldgs. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
11. The shares held by Crosslink Bayview VII, LLC ("CB VII") as reported herein reflect pro rata distributions in kind, effected by CB VII to its members for no additional consideration subsequent to the Reporting Person's most recent Form 4 filing, which were exempt from reporting pursuant to Rule 16a-13.
12. Shares are directly held by CB VII. CV VII Hldgs is the manager of CB VII and the Reporting Person is a managing member of CV VII Hldgs. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
13. The shares are held by an irrevocable trust, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his proportionate pecuniary interest therein.
14. The shares are held by a revocable trust, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his proportionate pecuniary interest therein.
/s/ James Feuille09/14/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading